Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era D Lea, S Håland, HR Hagland, K Søreide Scandinavian journal of gastroenterology 49 (10), 1153-1163, 2014 | 84 | 2014 |
Norwegian medical students’ attitudes towards the pharmaceutical industry D Lea, O Spigset, L Slørdal European journal of clinical pharmacology 66, 727-733, 2010 | 49 | 2010 |
Elevated microsatellite alterations at selected tetranucleotides in early‐stage colorectal cancers with and without high‐frequency microsatellite instability: Same, same but … MM Watson, D Lea, E Rewcastle, HR Hagland, K Søreide Cancer medicine 5 (7), 1580-1587, 2016 | 30 | 2016 |
Correlation of blood T-cells to intratumoural density and location of CD3+ and CD8+ T-cells in colorectal cancer HR Hagland, D Lea, MM Watson, K Søreide Anticancer Research 37 (2), 675-683, 2017 | 25 | 2017 |
Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based … K Søreide, MM Watson, D Lea, O Nordgård, JA Søreide, HR Hagland, ... Journal of translational medicine 14, 1-9, 2016 | 23 | 2016 |
A template to quantify the location and density of CD3+ and CD8+ tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective … D Lea, M Watson, I Skaland, HR Hagland, M Lillesand, E Gudlaugsson, ... Cancer Immunology, Immunotherapy 70, 2049-2057, 2021 | 16 | 2021 |
Digital image analysis of the proliferation markers Ki67 and phosphohistone H3 in gastroenteropancreatic neuroendocrine neoplasms: accuracy of grading compared with routine … D Lea, EG Gudlaugsson, I Skaland, M Lillesand, K Søreide, JA Søreide Applied Immunohistochemistry & Molecular Morphology 29 (7), 499-505, 2021 | 15 | 2021 |
Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer MM Watson, D Lea, E Gudlaugsson, I Skaland, HR Hagland, K Søreide Cancer Immunology, Immunotherapy 69, 1627-1637, 2020 | 15 | 2020 |
Elevated microsatellite alterations at selected tetranucleotides (EMAST) in colorectal cancer is associated with an elderly, frail phenotype and improved recurrence-free survival MM Watson, A Kanani, D Lea, RB Khajavi, JA Søreide, H Kørner, ... Annals of surgical oncology 27, 1058-1067, 2020 | 14 | 2020 |
Elevated microsatellite alterations at selected tetranucleotides (EMAST) is not attributed to MSH3 loss in stage I-III colon cancer: an automated, digitalized assessment by … MM Watson, D Lea, HR Hagland, K Søreide Translational Oncology 12 (12), 1583-1588, 2019 | 9 | 2019 |
The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study JA Søreide, JT Kvaløy, D Lea, OM Sandvik, M Al‐Saiddi, TM Haslerud, ... Cancer Reports 5 (2), e1462, 2022 | 7 | 2022 |
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer T Veen, A Kanani, D Lea, K Søreide Cancer Immunology, Immunotherapy 72 (10), 3135-3147, 2023 | 5 | 2023 |
Histopathological growth pattern in colorectal liver metastasis and the tumor immune microenvironment C Zaharia, T Veen, D Lea, A Kanani, M Alexeeva, K Søreide Cancers 15 (1), 181, 2022 | 5 | 2022 |
A case of Ménétriere´ s disease treated with the monoclonal antibody cetuximab A Carlsen, TB Grimstad, LN Karlsen, OJ Greve, KB Norheim, D Lea Clinical Journal of Gastroenterology 12, 562-565, 2019 | 4 | 2019 |
The gastrinoma saga before Zollinger and Ellison: the Strøm case revisited JA Søreide, D Lea Annals of surgery 270 (2), e19-e21, 2019 | 4 | 2019 |
Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and … D Lea, C Zaharia, K Søreide Cancer Treatment and Research Communications 38, 100788, 2024 | 2 | 2024 |
Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside. A Kanani, T Veen, M Alexeeva, D Lea, K Søreide Minerva Surgery, 2023 | 2 | 2023 |
Fremtidens patologi er digital D Lea, L Hatleskog Tidsskrift for Den norske legeforening, 2022 | 2 | 2022 |
Fatal adverse event with dabigatran in elderly patient with reduced kidney function SM Havig, D Lea, M Krpo, RM Skari, I Gustavsen, G Høiseth Basic & Clinical Pharmacology & Toxicology 123 (2), 221-226, 2018 | 2 | 2018 |
Correlation of circulating T-cells in pre-operative blood to intratumoral density and location of CD3+ and CD8+ T-cells in colorectal cancer: a potential for an immunoscore by … HR Hagland, D Lea, MMC Watson, K Søreide European Journal of Cancer 1 (72), S49-S50, 2017 | 2 | 2017 |